Skip to main content
Company record · Ixelles
Belgian companySituation normaleSociété à responsabilité limitée

EUROPEAN PAEDIATRIC MEDICINE COMPANY

Enterprise number
0888.748.741
VAT number
BE0888748741
Registered office
Avenue Louise 231, 1050 Ixelles
See the 498 companies at this address
Incorporated on
13 April 2007
Latest financial year
2025
m81-f model
Size
Micro
0 FTE
Equity
€605.5K
Financial year 2025
Net result
€576.3K
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

EUROPEAN PAEDIATRIC MEDICINE COMPANY is a Belgian company (Société à responsabilité limitée) whose registered office is established at 1050 Ixelles, inside the business centre Silversquare. Its main activity falls under “Autres activités de service de soutien aux entreprises nca” (NACE 82990).

Legal form
Société à responsabilité limitée
Legal situation
Situation normale
Date of incorporation
13 April 2007

Company names

Official names in several languages: legal name, trade name, abbreviation.

Abbreviation
  • EPMC Pharma

Domiciliation

Business centre hosting this company's registered office.

Silversquare
silversquare.eu473 entities at this address
See the centre

Anti-money-laundering (AML) compliance

Is this activity subject to the Belgian anti-money-laundering obligations? An indicative assessment based on the declared NACE code.

Conditional obligationCompany service provider (potential)

Given its declared activity (“Autres activités de service de soutien aux entreprises nca”), EUROPEAN PAEDIATRIC MEDICINE COMPANY may be subject to anti-money-laundering obligations, under the conditions below.

Some business services fall under company service providers, which are obliged entities.

Conditions: Covered if the company professionally provides third parties with one of these services: taking part in the purchase or sale of shares in a company (other than a listed one), providing a statutory seat, or providing a commercial, postal or administrative address and related services (registered office). The AMLR (EU) 2024/1624 will widen this perimeter on 10 July 2027 (company formation, director mandates, nominee arrangements).

Applicable obligations
  • Identification and verification of the client's identity (KYC)
  • Identification of the ultimate beneficial owners (UBO register)
  • Assessment of money-laundering and terrorist-financing risks
  • Ongoing diligence and monitoring of transactions
  • Reporting suspicions to the CTIF
  • Retention of the documents and appointment of an AMLCO

Legal basis: art. 5, §1, 29° of the Act of 18 September 2017, referring to art. 3, 1° of the Act of 29 March 2018.

General information based on the declared NACE activity code; it is not legal advice. Whether the obligations actually apply depends on the activity effectively carried out.

Your risk analysis on this company

AML Company ran EUROPEAN PAEDIATRIC MEDICINE COMPANY through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Ixelles

1 establishment · 1 municipality

Registered office1 establishment
Registered office
Avenue Louise 231
1050 Ixelles
Map
Establishment2163.668.340
Avenue Louise 523
1050 Ixelles
Map

Finances & financial health

Multi-year summary extracted from the annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium).

Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025€605,460€576,335
2022€449,877€435,420
2021€446,988€373,027
2020

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
47,4%
5,8%
Financial year 2025

Equity / balance sheet total

Liquidity
1,87 x
0,07
Financial year 2025

Current assets / debts due within one year

Net margin
-

This year's filing does not carry the item the calculation needs.

Result for the year / turnover

Operating margin
-

This year's filing does not carry the item the calculation needs.

Operating result / turnover

Long-term debt
0%
7,9%
Financial year 2025

Debts due after one year / balance sheet total

Return on equity
95,2%
1,6%
Financial year 2025

Result for the year / equity

Over the most recent filed years

Balance sheet structure

SolvencyLong-term debt
Year-on-year comparison
Ratio202520222021Trend
Solvency
47,4%
5,8%
41,6%
2,2%
43,8%
Liquidity
1,87 x
0,07
1,94 x
0,09
2,03 x
Net margin---
-
Operating margin---
-
Long-term debt
0%
7,9%
7,9%
0,5%
8,4%
Return on equity
95,2%
1,6%
96,8%
13,3%
83,5%

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (6)
Financial yearFilingFiling typeModelSource
01/01/202531/12/202506/05/2026Initialm81-fBNB
01/01/202231/12/202222/06/2023Initialm81-fBNB
01/01/202131/12/202120/07/2022Initialm81-fBNB
01/01/202031/12/202007/05/2021Initialm81-fBNB
01/01/201931/12/201923/07/2020Initialm01-fBNB
01/01/201831/12/201827/08/2019Initialm01-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about EUROPEAN PAEDIATRIC MEDICINE COMPANY

Quick answers on EUROPEAN PAEDIATRIC MEDICINE COMPANY's identity, contact details and official CBE information.

What is EUROPEAN PAEDIATRIC MEDICINE COMPANY's enterprise number (CBE)?
EUROPEAN PAEDIATRIC MEDICINE COMPANY's official enterprise number with the Crossroads Bank for Enterprises (CBE) is 0888748741. This unique number identifies the company with every Belgian administration.
What is EUROPEAN PAEDIATRIC MEDICINE COMPANY's VAT number?
EUROPEAN PAEDIATRIC MEDICINE COMPANY's intra-Community VAT number is BE0888748741. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is EUROPEAN PAEDIATRIC MEDICINE COMPANY's registered office?
EUROPEAN PAEDIATRIC MEDICINE COMPANY's registered office is located at Avenue Louise 231, 1050 Ixelles, Belgium. This address is the official one declared with the CBE.
What is EUROPEAN PAEDIATRIC MEDICINE COMPANY's legal form?
EUROPEAN PAEDIATRIC MEDICINE COMPANY is incorporated under the legal form “Société à responsabilité limitée”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was EUROPEAN PAEDIATRIC MEDICINE COMPANY incorporated?
EUROPEAN PAEDIATRIC MEDICINE COMPANY was entered in the Crossroads Bank for Enterprises on 13 April 2007. This date is the official start of activity declared with the CBE.
Is EUROPEAN PAEDIATRIC MEDICINE COMPANY still active?
Yes, EUROPEAN PAEDIATRIC MEDICINE COMPANY is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is EUROPEAN PAEDIATRIC MEDICINE COMPANY's main activity?
EUROPEAN PAEDIATRIC MEDICINE COMPANY's declared main activity is: Autres activités de service de soutien aux entreprises nca (NACE code 82990). This NACE code officially classifies the company in the European nomenclature of economic activities.
How many establishments does EUROPEAN PAEDIATRIC MEDICINE COMPANY have?
EUROPEAN PAEDIATRIC MEDICINE COMPANY declares 1 establishment unit registered with the CBE, on top of its registered office.
Has EUROPEAN PAEDIATRIC MEDICINE COMPANY filed its annual accounts?
Yes. EUROPEAN PAEDIATRIC MEDICINE COMPANY's latest annual accounts were filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 6 May 2026, for the financial year ended 31 December 2025. The filings can be consulted publicly with the NBB.
Which official notices concern EUROPEAN PAEDIATRIC MEDICINE COMPANY?
9 official notices about EUROPEAN PAEDIATRIC MEDICINE COMPANY are available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is EUROPEAN PAEDIATRIC MEDICINE COMPANY subject to anti-money-laundering obligations in Belgium?
It depends on the activity actually carried out. EUROPEAN PAEDIATRIC MEDICINE COMPANY (Company service provider (potential)) may be subject to anti-money-laundering obligations under certain conditions: Covered if the company professionally provides third parties with one of these services: taking part in the purchase or sale of shares in a company (other than a listed one), providing a statutory seat, or providing a commercial, postal or administrative address and related services (registered office). The AMLR (EU) 2024/1624 will widen this perimeter on 10 July 2027 (company formation, director mandates, nominee arrangements)..

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
15 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 26 June 2026Registered officeView the notice26081811
    2. 6 May 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m81-fFiled accounts2026-00108426
  2. 2023
    1. 27 December 2023Company name · Legal form · Appointments · ResignationsView the notice23476234
    2. 22 June 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m81-fFiled accounts2023-00147341
  3. 2022
    1. 20 July 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m81-fFiled accounts2022-20207095
  4. 2021
    1. 7 May 2021Annual accounts filed·Financial year ended 31 December 2020 · Model m81-fFiled accounts2021-13800323
  5. 2020
    1. 23 July 2020Annual accounts filed·Financial year ended 31 December 2019 · Model m01-fFiled accounts2020-33500295
  6. 2019
    1. 27 August 2019Annual accounts filed·Financial year ended 31 December 2018 · Model m01-fFiled accounts2019-52500362
  7. 2016
    1. 28 January 2016Capital · SharesView the notice16015052
  8. 2015
    1. 24 June 2015Registered officeView the notice15089190
  9. 2014
    1. 14 May 2014Appointments · ResignationsView the notice14098694
  10. 2013
    1. 1 August 2013Appointments · ResignationsView the notice13120484

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.